Attached files
| file | filename |
|---|---|
| 10-K - 10-K - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231x10k.htm |
| EX-32.2 - EX-32.2 - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231ex322f4f968.htm |
| EX-32.1 - EX-32.1 - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231ex321bd4b42.htm |
| EX-31.2 - EX-31.2 - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231ex31216b33c.htm |
| EX-31.1 - EX-31.1 - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231ex311320050.htm |
| EX-23.2 - EX-23.2 - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231ex23272f272.htm |
| EX-21.1 - EX-21.1 - COLLEGIUM PHARMACEUTICAL, INC | coll-20161231ex211ca1421.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-213964 on Form S-3 and Registration Statement No. 333-207744 on Form S-8 of our report dated March 10, 2017, relating to the consolidated financial statements of Collegium Pharmaceutical, Inc. and subsidiary, appearing in this Annual Report on Form 10-K of Collegium Pharmaceutical, Inc. for the year ended December 31, 2016.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 10, 2017
|
|
|
|
|
|